decibel regeneron hearing loss drug research

Decibel Therapeutics Announces Collaboration with Regeneron to Develop New Drugs to Treat Hearing Loss

Boston-based biotech firm, Decibel Therapeutics, announced a collaboration with Regeneron Pharmaceuticals to boost research efforts to “discover and develop new potential therapeutics to protect, repair, and restore hearing”. As part of the effort, Regeneron will get an equity stake in Decibel and receive royalty payments if the company’s treatments get approved.   Decibel Theraputics, which…

Read More